Share：
Share this content in WeChat
X
[Chinese][PDF]1041
• Lecture •
Uncommon imaging features in patients with autoimmune pancreatitis
ZHANG Binbin  DAI Na  YANG Ying  HUO Jianwei  JIN Erhu 

Cite this article as: ZHANG B B, DAI N, YANG Y, et al. Uncommon imaging features in patients with autoimmune pancreatitis[J]. Chin J Magn Reson Imaging, 2024, 15(6): 123-128. DOI:10.12015/issn.1674-8034.2024.06.018.


[Abstract] Autoimmune pancreatitis (AIP) is a special type of inflammation of the pancreas, its common imaging features have been well known by radiologists and have served as the indispensable evidence for establishing the diagnosis of AIP. Whereas we have also found that in addition to the common imaging features in clinical practice, AIP sometimes presents with uncommon imaging features such as the pancreatic duct dilation, pancreatic cystic lesions, involvement of peripancreatic blood vessels, pancreatic calcification and pancreatic duct stones, marked pancreatic parenchymal atrophy within one year following steroids treatment, concurrent malignant tumors, and so on. In order to deepen comprehensive recognition for the imaging manifestations of AIP, this article introduced the uncommon CT and MRI findings of AIP.
[Keywords] autoimmune pancreatitis；X-ray computed tomography；magnetic resonance imaging；cystic lesions of pancreas；pancreatic atrophy；malignant tumor

ZHANG Binbin1   DAI Na1   YANG Ying1   HUO Jianwei1   JIN Erhu2*  

1 Department of Radiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China

2 Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

Corresponding author: JIN E H, E-mail: erhujin@263.net

Conflicts of interest   None.

Received  2024-02-20
Accepted  2024-06-06
DOI: 10.12015/issn.1674-8034.2024.06.018
Cite this article as: ZHANG B B, DAI N, YANG Y, et al. Uncommon imaging features in patients with autoimmune pancreatitis[J]. Chin J Magn Reson Imaging, 2024, 15(6): 123-128. DOI:10.12015/issn.1674-8034.2024.06.018.

[1]
SHIMOSEGAWA T, CHARI S T, FRULLONI L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40(3): 352-358. DOI: 10.1097/MPA.0b013e3182142fd2.
[2]
ZHANG B B, JIN E H, CHEN G Y, et al. MRI features and follow-up analysis of autoimmune pancreatitis[J]. Int J Med Radiol, 2016, 39(2): 111-115. DOI: 10.19300/j.2016.l3365.
[3]
ZHONG S T, HUANG X H, QIN S Z, et al. Advances in imaging differential diagnosis of autoimmune pancreatitis and pancreatic cancer[J]. Chin J Magn Reson Imag, 2023, 14(8): 165-170. DOI: 10.12015/issn.1674-8034.2023.08.029.
[4]
DONG L N, YAN W, ZHANG J, et al. A study of the correlations between CT and MRI findings and elevated serum IgG4 levels in newly-diagnosed patients with IgG4-related sclerosing cholangitis[J]. Comput Tomogr Theory Appl, 2023, 32(2): 231-239. DOI: 10.15953/j.ctta.2022.158.
[5]
JIA H H, LI J L, HUANG W J, et al. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma[J/OL]. BMC Med Imaging, 2021, 21(1): 149 [2023-12-01]. https://pubmed.ncbi.nlm.nih.gov/34654379/. DOI: 10.1186/s12880-021-00679-0.
[6]
NEGRELLI R, MANFREDI R, PEDRINOLLA B, et al. Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings[J]. Eur Radiol, 2015, 25(2): 359-367. DOI: 10.1007/s00330-014-3371-y.
[7]
MENG Q Q, XIN L, LIU W Y, et al. Diagnosis and treatment of autoimmune pancreatitis in China: a systematic review[J/OL]. PLoS One, 2015, 10(6): e0130466 [2024-01-12]. https://pubmed.ncbi.nlm.nih.gov/26110658/. DOI: 10.1371/journal.pone.0130466.
[8]
ZHANG B B, JIN E H. MRCP features of pancreatic duct lesions in autoimmune pancreatitis[J]. Chin J Med Imag Technol, 2017, 33(2): 232-236. DOI: 10.13929/j.1003-3289.201608151.
[9]
ZHANG B B, HOU X M, CHEN Y Q, et al. Imaging features and risk factors of pancreatic cystic lesions complicating autoimmune pancreatitis: a retrospective study[J/OL]. Curr Med Imaging, 2023 [2024-01-12]. https://pubmed.ncbi.nlm.nih.gov/36918786/. DOI: 10.2174/1573405619666230314095508.
[10]
YOON S B, JEON T Y, MOON S H, et al. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma[J]. Eur Radiol, 2022, 32(10): 6691-6701. DOI: 10.1007/s00330-022-08816-1.
[11]
CUI X B, XU W, ZHANG Y C, et al. Autoimmune pancreatitis with pancreatic calculi and pseudocyst: a case report[J/OL]. J Int Med Res, 2021, 49(5): 3000605211014798 [2023-12-23]. https://pubmed.ncbi.nlm.nih.gov/34034562/. DOI: 10.1177/03000605211014798.
[12]
KOIZUMI K, MASUDA S, TAZAWA T, et al. Endoscopic ultrasonography-guided drainage for spontaneous rupture of a pancreatic pseudocyst into the peritoneal cavity in a patient with autoimmune pancreatitis[J]. Clin J Gastroenterol, 2020, 13(4): 591-596. DOI: 10.1007/s12328-020-01104-9.
[13]
HEO W G, KIM T H, KIM Y J, et al. Autoimmune pancreatitis complicated with pancreatic ascites, pancreatic ductal leakage, and multiple pseudocyst[J/OL]. Pancreas, 2017, 46(1): e10-e11 [2023-12-23]. https://pubmed.ncbi.nlm.nih.gov/27977636/. DOI: 10.1097/MPA.0000000000000687.
[14]
MATSUBAYASHI H, KUBOTA K. Pancreatic cystic lesions in cases of autoimmune pancreatitis[J/OL]. Pancreas, 2019, 48(2): e14 [2023-12-23]. https://pubmed.ncbi.nlm.nih.gov/30640232/. DOI: 10.1097/MPA.0000000000001213.
[15]
DONET J A, BARKIN J A, KEIHANIAN T, et al. Pancreatic pseudocysts and parenchymal necrosis in patients with autoimmune pancreatitis: a systematic review[J]. Pancreas, 2018, 47(8): 952-957. DOI: 10.1097/MPA.0000000000001121.
[16]
KURAISHI Y, WATANABE T, MURAKI T, et al. Effectiveness of steroid therapy for pancreatic cysts complicating autoimmune pancreatitis and management strategy for cyst-related complications[J]. Scand J Gastroenterol, 2019, 54(6): 773-779. DOI: 10.1080/00365521.2019.1623307.
[17]
KUBOTA K, FUJITA Y, SATO T, et al. Autoimmune pancreatitis associated with pancreatic cyst: how can we manage it?[J]. J Hepatobiliary Pancreat Sci, 2014, 21(12): 902-910. DOI: 10.1002/jhbp.160.
[18]
KIM M J, SONG T J, KIM H J, et al. Coexisting mucinous cystic neoplasm of the pancreas and type 1 autoimmune pancreatitis[J]. J Pathol Transl Med, 2019, 53(2): 125-128. DOI: 10.4132/jptm.2018.10.25.
[19]
LI M Z, BAI X Y, XU K, et al. Peripancreatic vascular involvement in patients with type 1 autoimmune pancreatitis[J]. Hepatobiliary Surg Nutr, 2022, 11(3): 355-362. DOI: 10.21037/hbsn-21-82.
[20]
ISHIKAWA T, ITOH A, KAWASHIMA H, et al. Peripancreatic vascular involvements of autoimmune pancreatitis[J]. J Gastroenterol Hepatol, 2012, 27(12): 1790-1795. DOI: 10.1111/j.1440-1746.2012.07248.x.
[21]
ZHANG B B, DAI N, YANG Y, et al. CT and MRI feature analysis of pseudocapsule in autoimmune pancreatitis[J]. Int J Med Radiol, 2023, 46(5): 537-542. DOI: 10.19300/j.2023.L20311.
[22]
GOTO N, MIMURA J, ITANI T, et al. Autoimmune pancreatitis complicated by gastric varices: a report of 3 cases[J]. World J Gastroenterol, 2012, 18(31): 4228-4232. DOI: 10.3748/wjg.v18.i31.4228.
[23]
HAO N B, LI X, HU W W, et al. Steriod for Autoimmune pancreatitis complicating by gastric varices: a case report[J]. World J Clin Cases, 2022, 10(12): 3930-3935. DOI: 10.12998/wjcc.v10.i12.3930.
[24]
TOSHIMA F, INOUE D, KOMORI T, et al. Qualitative and quantitative evaluation for morphological changes of the splenic artery in autoimmune pancreatitis: novel imaging findings for differentiation from pancreatic adenocarcinoma[J]. Abdom Radiol, 2018, 43(12): 3357-3366. DOI: 10.1007/s00261-018-1634-9.
[25]
SAWACHIKA H, FUJITA S, MUKAI T, et al. IgG4-related autoimmune pancreatitis complicated by splenic artery pseudoaneurysm[J/OL]. BMJ Case Rep, 2018, 2018: bcr2018224589 [2024-01-12]. https://pubmed.ncbi.nlm.nih.gov/29507039/. DOI: 10.1136/bcr-2018-224589.
[26]
MARUYAMA M, WATANABE T, KANAI K, et al. Autoimmune pancreatitis can develop into chronic pancreatitis[J/OL]. Orphanet J Rare Dis, 2014, 9: 77 [2023-12-01]. https://pubmed.ncbi.nlm.nih.gov/24884922/. DOI: 10.1186/1750-1172-9-77.
[27]
TAKAYAMA M, HAMANO H, OCHI Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation[J]. Am J Gastroenterol, 2004, 99(5): 932-937. DOI: 10.1111/j.1572-0241.2004.04162.x.
[28]
TAKADA H, NAKAZAWA T, OHARA H, et al. Role of osteopontin in calcification in autoimmune pancreatitis[J]. Dig Dis Sci, 2009, 54(4): 793-801. DOI: 10.1007/s10620-008-0418-4.
[29]
MARUYAMA M, ARAKURA N, OZAKI Y, et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients[J/OL]. Int J Rheumatol, 2013, 2013: 272595 [2023-12-01]. https://pubmed.ncbi.nlm.nih.gov/23762066/. DOI: 10.1155/2013/272595.
[30]
ZHANG Y R, MENG Q Q, XIN L, et al. Research progress on long-term prognosis of autoimmune pancreatitis[J]. Chin J Pancreatol, 2022, 22(2): 144-147. DOI: 10.3760/cma.j.cn115667-20210511-00097.
[31]
KAWA S, HAMANO H, OZAKI Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence[J]. Clin Gastroenterol Hepatol, 2009, 7(11Suppl): S18-S22. DOI: 10.1016/j.cgh.2009.07.041.
[32]
MARUYAMA M, ARAKURA N, OZAKI Y, et al. Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course[J]. J Gastroenterol, 2012, 47(5): 553-560. DOI: 10.1007/s00535-011-0510-y.
[33]
ITO T, KAWA S, MATSUMOTO A, et al. Risk factors for pancreatic stone formation in type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 624 patients[J]. Pancreas, 2019, 48(1): 49-54. DOI: 10.1097/MPA.0000000000001210.
[34]
TAKUMA K, KAMISAWA T, TABATA T, et al. Short-term and long-term outcomes of autoimmune pancreatitis[J]. Eur J Gastroenterol Hepatol, 2011, 23(2): 146-152. DOI: 10.1097/meg.0b013e3283431e23.
[35]
ITO T, NAKAMURA T, FUJIMORI N, et al. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis[J]. J Dig Dis, 2011, 12(3): 210-216. DOI: 10.1111/j.1751-2980.2011.00498.x.
[36]
MASUDA A, SHIOMI H, MATSUDA T, et al. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis[J]. Pancreatology, 2014, 14(5): 361-365. DOI: 10.1016/j.pan.2014.07.005.
[37]
YAMADA Y, MASUDA A, SOFUE K, et al. Prediction of pancreatic atrophy after steroid therapy using equilibrium-phase contrast computed tomography imaging in autoimmune pancreatitis[J]. JGH Open, 2020, 4(4): 677-683. DOI: 10.1002/jgh3.12316.
[38]
LU J P. Pancreatic pathology and radiology[M]. Shanghai: Shanghai Scientific & Technical Publishers, 2019: 148-182.
[39]
LI M Z, GUO T, FENG Y L, et al. Diabetes mellitus in patients with type 1 autoimmune pancreatitis at diagnosis and after corticosteroid therapy[J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 393-398. DOI: 10.1016/j.hbpd.2023.04.006.
[40]
ZHOU C H, ZOU D W. Progresses and hot spots of type 1 autoimmune pancreatitis in the past decade[J]. Chin J Intern Med, 2024, 63(1): 13-16. DOI: 10.3760/cma.j.cn112138-20231015-00215.
[41]
MACINGA P, BAJER L, DEL CHIARO M, et al. Pancreatic cancer in patients with autoimmune pancreatitis: a scoping review[J]. Pancreatology, 2021, 21(5): 928-937. DOI: 10.1016/j.pan.2021.03.007.
[42]
OKAMOTO A, WATANABE T, KAMATA K, et al. Recent updates on the relationship between cancer and autoimmune pancreatitis[J]. Intern Med, 2019, 58(11): 1533-1539. DOI: 10.2169/internalmedicine.2210-18.
[43]
MIYAGAWA K, KUMAMOTO K, SHINOHARA N, et al. Autoimmune pancreatitis with gastric cancer: some IgG4-related diseases may be paraneoplastic syndrome[J]. Intern Med, 2022, 61(14): 2155-2160. DOI: 10.2169/internalmedicine.8590-21.

PREV Effect on image quality of ultra-high b-values diffusion weighted imaging in patients with rectal cancer by using different bowel preparation methods
NEXT Adult diffuse intrinsic pontine glioma with vertebral canal dissemination: One case report and literature review
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn